Federal Register - August 2, 2021

Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.

Fuente: Federal Register

Federal Register / Vol. 86, No. 145 / Monday, August 2, 2021 / Notices DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection;
Comment Request In compliance with Section 3506c2A of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration SAMHSA
will publish periodic summaries of proposed projects. To request more information on the proposed project or to obtain a copy of the information collection plans, call the SAMHSA
Reports Clearance Officer at 240 276
0361.
Comments are invited on: a Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;
b the accuracy of the agencys estimate of the burden of the proposed collection of information; c ways to enhance the quality, utility, and clarity of the information to be collected; and d ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology.

khammond on DSKJM1Z7X2PROD with NOTICES

Project: State Opioid Response SOR/
Tribal Opioid Response TOR Program Instrument OMB No. 09300384
Revision SAMHSA is requesting approval to modify its existing CSAT SOR/TOR
Program Instrument by 1 collapsing the original three questions into two questions for clarity and 2 adding ten questions, in order to collect information on Congressionally mandated and programmatic activities and comply with reporting requirements. The program-level information is collected quarterly and entered and stored in SAMHSAs Performance Accountability and Reporting System, which is a real-time, performance management system that captures information on the substance abuse prevention and treatment and mental health services delivered in the United States. Continued approval of
VerDate Sep<11>2014

17:21 Jul 30, 2021

Jkt 253001

this information collection will allow SAMHSA to continue to meet Government Performance and Results Modernization Act GPRA of 2010
reporting requirements that quantify the effects and accomplishments of its discretionary grant programs.
The SOR/TOR programs were first authorized under Title II Division H of the Consolidated Appropriations Act, 2018, Public Law 115141. SOR/TOR
programs aim to address the opioid crisis by increasing access to medication-assisted treatment using the three FDA-approved medications for the treatment of Opioid Use Disorder OUD, reducing unmet treatment need, and reducing opioid overdose-related deaths through the provision of prevention, treatment and recovery activities for OUD including illicit use of prescription opioids, heroin, and fentanyl and fentanyl analogs.
SAMHSA is proposing to revise the SOR/TOR Program Instrument data collection instrument OMB No. 0930
0384, in order to collect information on Congressionally mandated and programmatic activities and comply with reporting requirements.
SAMHSA developed the SOR/TOR
Program Instrument to collect minimum data on naloxone purchase and distribution, but the SOR/TOR programs are unique in that they have prevention requirements. SOR/TOR grantees are required to engage in the following prevention activities: 1 Implement prevention and education services, including training of peers and first responders on recognition of opioid overdose and appropriate use of the opioid overdose antidote naloxone, 2
develop evidence-based community prevention efforts, including strategic messaging on the consequences of opioid misuse, and 3 purchase and distribute naloxone and train on its use.
The revised tool will allow SAMHSA to collect data on the required education and prevention activities, and better assess grantee performance on these activities.
Based on a recent United States Government Accountability Office GAO Report to Congress GAO 2196, Drug Misuse: Agencies Have Not Fully Identified How Grants That Can Support Drug Prevention Education Programs Contribute to National Goals, 1 GAO
1 United States Government Accountability Office. 2020, November. Drug Misuse: Agencies
PO 00000

Frm 00063

Fmt 4703

Sfmt 4703

41495

found that SAMHSAs performance measures for the SOR program partially reflect its core program activities, and that although SAMHSA reported three performance measures for the SOR
program, all three measures focused on treatment or recovery services only.
GAO recommended, and SAMHSA
committed to, implementing the following: The Secretary of Health and Human Services should determine how the State Opioid Response program contributes to the prevention goals of the National Drug Control Strategy and develop performance measures that relate to achieving those goals including the prevention education goal.
Collection of the data in the revised tool will enable SAMHSA to implement the recommendations of GAO.
Finally, the revisions will assist SAMHSA in providing comprehensive data on the full range of required activities to inform Congressionally mandated reports for the SOR program.
In order to address these issues, SAMHSA is proposing to 1 collapse the three questions into two questions for clarity and 2 add ten questions, in order to collect information on Congressionally mandated and programmatic activities and comply with reporting requirements. A
summary of the proposed changes includes:
The revised question will provide CSAT with clarification on the purchase and distribution of naloxone kits.
The ten additional questions will provide data on the following:
Reported overdose reversals;
Purchase and distribution of fentanyl test strips;
Training of first responders and key community sectors on recognizing an opioid overdose and the appropriate use of naloxone overdose reversal kits;
Educating individuals, including school-aged children, on the consequences of opioid and/or stimulant misuse using strategic messaging and prevention activities;
Training individuals to provide school-based prevention and education activities to school-aged children; and Providing targeted prevention outreach activities to underserved and/
or diverse populations.
Have Not Fully Identified How Grants That Can Support Drug Prevention Education Programs Contribute to National Goals. https www.gao.gov/
assets/gao-21-96.pdf.

E:FRFM02AUN1.SGM

02AUN1

Acerca de esta edición

Federal Register - August 2, 2021

TítuloFederal Register

PaísEstados Unidos de América

Fecha02/08/2021

Nro. de páginas328

Nro. de ediciones7802

Primera edición14/03/1936

Ultima edición25/06/2026

Descargar esta edición

Otras ediciones

<<<Agosto 2021>>>
DLMMJVS
1234567
891011121314
15161718192021
22232425262728
293031